PUBLIC CONTRACT · 2021
Aprov-Vr 21002144 - 22000159 - AP 1419
- Contract value
- €42.50
- Signed on
- 31 August 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7819248PUBLISHED SUBJECT
AP 1419 aquisição de 1.288 unidades Losartan 50 mg Comp
Parties involved
- Place of performance
- Portugal, Porto, Maia; Portugal, Vila Real, Vila Real; Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GENERIS FARMACÊUTICA,SA · Tax ID 508107997
- Bidder
- LABORATORIO MEDINFAR-PRODUTOS FARMACEUTICOS S.A. · Tax ID 500384045
- Bidder
- FARMOZ, S.A. · Tax ID 501505334
Values and timeline
- Contract price
- €42.50
- Procedure base price
- €1,975.64
- Total effective price
- €42.50
- Publication date
- 31 August 2021
- Award date
- 23 August 2021
- Signing date
- 31 August 2021
- Performance period
- 518 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33622000-6 - Medicamentos para o aparelho cardiovascular
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2020/1 - Medicamentos do aparelho cardiovascular
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5411142
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.